top of page

Our Pipeline

Our foundation is built on a pipeline of four programs targeting influenza, BK polyomavirus, human rhinovirus, and adenovirus. We are committed to advancing this initial pipeline with additional discovery efforts to follow.

via nova therapeutics pipeline influenza A.png

Influenza A

Small molecule inhibitor of influenza A with a novel MOA for treatment of seasonal influenza.

Discovery

Hit to Lead

Lead Op

IND Enabling

Phase 1

Phase 2

via nova therapeutics pipeline BKV.png

BK Polyomavirus

Small molecule inhibitor for the treatment or prevention of BKV-induced renal disease following kidney transplant.

Discovery

Hit to Lead

Lead Op

IND Enabling

Phase 1

Phase 2

via nova therapeutics pipeline rhinovirus.png

Human Rhinovirus

Small molecule polymerase inhibitor of human rhinovirus for prevention of asthma exacerbations.

Discovery

Hit to Lead

Lead Op

IND Enabling

Phase 1

Phase 2

via nova therapeutics pipeline adenovirus.png

Adenovirus

Small molecule inhibitor for the treatment of ocular infections in otherwise healthy individuals and severe systemic infections in immunocompromised patients.

Discovery

Hit to Lead

Lead Op

IND Enabling

Phase 1

Phase 2

bottom of page